@LABMT2 profile picture
LABMT @LABMT2

Latin American Bone Marrow Transplantation Group - Helping HSCT growth in the Region - Sharing information - Strengthening ties!

Joined February 2020
  • Tweets 571
  • Following 780
  • Followers 1,064
37 Photos and videos
LABMT@LABMT2
May 21
Do not miss our upcoming webinar on the #EBMT26 highlights later today! 4:00 PM Mexico city time. Register here: us06web.zoom.us/meeting/regi… @TheEBMT #BMTsm
1
1
92
LABMT@LABMT2
Mar 21
Join @LABMT2 activities at #EBMT26 on March 23! See you πŸ”œ @TheEBMT #BMTsm #CARTcells
3
9
320
LABMT@LABMT2
Feb 7
Don't forget to meet us tonight at 8:00 PM! @LABMT2 #Tandem26 @ASTCT
LABMT@LABMT2
Feb 1
Let's meet at #Tandem26 come and join us! @ASTCT #BMTsm #CARTcells
1
136
LABMT@LABMT2
Feb 6
πŸ‡²πŸ‡½ Gomez-De-Leon 469 πŸ“˜ Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia: The Mexican Experience A national multicenter snapshot of outcomes, challenges, and collaboration in ALL transplantation. #Tandem26 #BMTsm
1
2
74
LABMT@LABMT2
Feb 6
πŸ‡§πŸ‡· Brazil Schmidt-Filho 784 🦠 Real-World Effectiveness of Letermovir Prophylaxis after Allogeneic HCT in a Middle-Income Country Real-world data show reduced CMV reactivation and no resistant infections with letermovir prophylaxis. #Tandem26 #BMTsm
1
47
LABMT@LABMT2
Feb 6
πŸ‡²πŸ‡½ Ugarte-Pelaez πŸ₯ Outpatient Allogeneic Hematopoietic Stem Cell Transplantation: Feasibility, Hospitalization Predictors, and Early Mortality Over 40% fully outpatient HSCTβ€”feasible, safe, and cost-saving. #Tandem26 #BMTsm
1
3
119
LABMT@LABMT2
Feb 6
πŸ‡§πŸ‡· Gibran-Nunes 528 πŸ’Š Loncastuximab Tesirine in Heavily Pretreated DLBCL, Including the Post–CAR-T Setting: A Meta-Analysis Systematic review shows meaningful activity with manageable toxicity in advanced DLBCL. #Tandem26 #BMTsm
69
LABMT@LABMT2
Feb 6
πŸ‡²πŸ‡½ Frausto 405 🌎 Breaking Geographic Barriers in a Mexican Ambulatory Transplant Program Early outcomes show equitable access and comparable survival for national and international patients. #Tandem26 #BMTsm
1
2
60
LABMT@LABMT2
Feb 6
πŸ‡²πŸ‡½ GonzΓ‘lez-Lozano 175 πŸš€ Safety and Feasibility of Outpatient Myeloablative TMLI-Based Allogeneic Transplantation in High-Risk ALL Phase I/II trial supporting outpatient delivery with encouraging survival and safety. #Tandem26 #BMTsm
1
3
312
LABMT@LABMT2
Feb 6
πŸ‡²πŸ‡½ Morcos-Sandino 252 πŸ‘οΈ Topical Cyclosporine vs Tacrolimus for Ocular GVHD Prophylaxis after Allogeneic HSCT Phase I–II trial supporting safe and feasible ocular GVHD prevention strategies. #Tandem26 #BMTsm
1
71
LABMT@LABMT2
Feb 6
πŸ‡§πŸ‡· Arcuri 246 πŸ§ͺ Joint Use of Rabbit ATG and Posttransplant Cyclophosphamide for HLA-Matched PBSC Transplantation: The Jurassic Phase I/II Trial Early results support a calcineurin inhibitor–free GVHD prophylaxis strategy. #Tandem26 #BMTsm
1
85
LABMT@LABMT2
Feb 6
πŸ‡²πŸ‡½ Sotomayor 378 πŸ›‘οΈ Post-Transplant Cyclophosphamide for GVHD Prophylaxis in HLA-Matched Related Donor HSCT Real-world outcomes from a Latin American center supporting PTCy in MRD transplants. #Tandem26 #BMTsm
1
61
LABMT@LABMT2
Feb 6
πŸ‡§πŸ‡· | Barroso Duarte 406 βš–οΈ Comparative Outcomes of Allogeneic HCT in MDS/MPN versus Other Myelodysplastic Syndromes Registry data confirm inferior survival in MDS/MPN, underscoring the need for tailored strategies. #Tandem26 #BMTsm
2
75
LABMT@LABMT2
Feb 6
πŸ‡²πŸ‡½ Burgos-Canales 475 πŸ“Š Non-Relapse Mortality in Acute Leukemia: Haploidentical vs Matched Related Donor Unicentric Mexican experience showing comparable NRM across donor platforms. #Tandem26 #BMTsm
1
70
LABMT@LABMT2
Feb 5
πŸ‡²πŸ‡½ Montemayor-Mora 474 πŸ”„ Comparative Outcomes between Haploidentical and HLA-Identical Related HSCT in Northeastern Mexico Real-world evidence supporting haploidentical transplant as an effective alternative in LMICs. #Tandem26 #BMTsm
3
68
LABMT@LABMT2
Feb 5
πŸ‡²πŸ‡½ Ugarte-Pelaez 489 πŸ”— Short-Duration Blinatumomab for Residual Disease Eradication as a Bridge to Transplant in B-ALL Innovative, resource-adapted strategy showing high MRD clearance before HCT. #Tandem26 #BMTsm
1
2
66
LABMT@LABMT2
Feb 5
πŸ‡§πŸ‡· | Simioni 496 πŸ“ˆ Improving Hematopoietic Cell Transplantation Follow-up Data: Completeness Index Assessment of Brazilian Registry Centers How systematic monitoring and feedback improved national transplant registry data quality. #Tandem26 #BMTsm
1
64
LABMT@LABMT2
Feb 5
πŸ‡²πŸ‡½ Armillas-Canseco πŸ₯ Early Hospital Readmission after Allogeneic Hematopoietic Cell Transplantation Haploidentical donors and bacterial infections identified as key drivers of early readmission risk. #Tandem26 #BMTsm
1
95
LABMT@LABMT2
Feb 5
International | Fingrut 🌍 Inclusive Practices for Safe and Equitable Donor Assessment Global consensus recommendations to advance donor safety, equity, and inclusion across registries and centers. #Tandem26 #BMTsm
40
LABMT retweeted
LABMT@LABMT2
Feb 1
Let's meet at #Tandem26 come and join us! @ASTCT #BMTsm #CARTcells
5
13
1,303
Load more